It does not seem unreasonable that along with mandating data availability, journals should begin insisting that minimum patient and tumor clinicopathologic information is provided (such as sex, age, and race or hospital, along with histologic grade, nodal status, ER, and HER2 status) for all samples for studies to be published. Here, ERBB2 is linked to neoplasm.